TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22321976

Group type: EXPERIMENTAL
Intervention: Aerobic exercise program, supervised for 6 sessions followed by home-based training.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Non-exercise group (daily activities).
Number of subjects: 50
Study: 18287414

Group type: EXPERIMENTAL
Intervention: Immediate cytologic analysis
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: Immediate subtyping
Number of subjects: 472
Study: 16922471

Group type: EXPERIMENTAL
Intervention: Short-term donepezil therapy (3 months)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Long-term donepezil therapy (1 year)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Pre-treatment levels
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Absolute rCBF
Number of subjects: 17
Study: 12830444

Group type: EXPERIMENTAL
Intervention: Short daily HD
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Long nocturnal HD
Number of subjects: 44

Group type: COMPARATOR
Intervention: Conventional thrice-weekly HD
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Daily HD
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Nocturnal HD
Number of subjects: 44
Study: 10831898

Group type: EXPERIMENTAL
Intervention: Ofloxacin alone
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Ofloxacin with Refresh Plus
Number of subjects: 18
Study: 9342998

Group type: EXPERIMENTAL
Intervention: Stress management training
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 107

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Stress management
Number of subjects: 107
Study: 30028930

Group type: EXPERIMENTAL
Intervention: Diode Laser (DL)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Gingival Retraction Cords (RC)
Number of subjects: 74
Study: 27664561

Group type: EXPERIMENTAL
Intervention: 2000 impulses of ESWT at 24 Kv (Group A)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 4000 impulses of ESWT (Group B)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 6000 impulses of ESWT (Group C)
Number of subjects: 33
Study: 24860173

Group type: EXPERIMENTAL
Intervention: Aerobic training (3-4 times per week for 8 weeks)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 16
Study: 22327082

Group type: EXPERIMENTAL
Intervention: Whole-Body Vibration (WBV) training
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 10
Study: 19690268

Group type: EXPERIMENTAL
Intervention: HES 130/0.4
Number of subjects: 40

Group type: COMPARATOR
Intervention: 5% human albumin
Number of subjects: 40
Study: 17021429

Group type: EXPERIMENTAL
Intervention: 99mTc-Technegas SPECT imaging
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 133Xe dynamic SPECT imaging
Number of subjects: 17

Group type: COMPARATOR
Intervention: HRCT imaging
Number of subjects: 17
Study: 15025654

Group type: EXPERIMENTAL
Intervention: Axial load of 250 h and 45 kg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Non-axial load of 250 h and 45 kg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (unloaded tooth)
Number of subjects: 18
Study: 11751742

Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 38
Study: 9222672

Group type: EXPERIMENTAL
Intervention: 500 U/kg of r‐HuEPO divided in three doses (300 U/kg 12 days before surgery, 100 U/kg 4 and 8 days later)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 500 U/kg of r‐HuEPO (300 U/kg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 500 U/kg of r‐HuEPO (100 U/kg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (surgery without delay)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Experimental group (r‐HuEPO treatment)
Number of subjects: 20
Study: 7678586

Group type: EXPERIMENTAL
Intervention: HibCP-TT followed by HibCP-DT
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: HibCP-DT followed by HibCP-TT
Number of subjects: 82

Group type: COMPARATOR
Intervention: Preimmunization with carrier protein (TT or DT)
Number of subjects: 82
Study: 3616754

Group type: EXPERIMENTAL
Intervention: Narcotic analgesic (meperidine hydrochloride) plus antispasmodics (diazepam and baclofen)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Narcotic analgesic (meperidine hydrochloride) alone
Number of subjects: 50
Study: 31948462

Group type: EXPERIMENTAL
Intervention: Patient-driven surgical safety checklist
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Focus group interviews
Number of subjects: 52
Study: 29708654

Group type: EXPERIMENTAL
Intervention: Novel pocket irrigator/evacuator device (IED)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Conventional subgingival debridement (CPT)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: IED
Number of subjects: 25

Group type: COMPARATOR
Intervention: CPT
Number of subjects: 25
Study: 27515838

Group type: EXPERIMENTAL
Intervention: Take-home training on box trainers
Number of subjects: 18
Study: 23963049

Group type: EXPERIMENTAL
Intervention: Visual-only strategies
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Verbal + visual strategies
Number of subjects: 192

Group type: COMPARATOR
Intervention: Untreated control
Number of subjects: 192
Study: 23635616

Group type: EXPERIMENTAL
Intervention: Minimal residue diet plus mechanical bowel preparation with oral sodium picosulphate
Number of subjects: 308

Group type: COMPARATOR
Intervention: Fasting only
Number of subjects: 308

Group type: COMPARATOR
Intervention: Minimal residue diet for 2 days
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Minimal residue diet plus mechanical bowel preparation
Number of subjects: 308
Study: 19558378

Group type: EXPERIMENTAL
Intervention: History of previous acute ankle injuries
Number of subjects: 508

Group type: EXPERIMENTAL
Intervention: FAOS sub-score 'Pain'
Number of subjects: 508

Group type: EXPERIMENTAL
Intervention: Functional tests and clinical examination
Number of subjects: 508
Study: 17884341

Group type: EXPERIMENTAL
Intervention: Tri E Tocotrienol 160 mg daily for 6 months
Number of subjects: 64
Study: 16965592

Group type: EXPERIMENTAL
Intervention: 300 UI per kg rHuEPO
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 600 UI per kg rHuEPO
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 12768071

Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 28
Study: 11203592

Group type: EXPERIMENTAL
Intervention: EDTA gel
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control group (no EDTA gel)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Referral patients
Number of subjects: 91

Group type: COMPARATOR
Intervention: Maintenance care patients
Number of subjects: 91
Study: 9337677

Group type: EXPERIMENTAL
Intervention: High-dose interferon (IFN)
Number of subjects: 280

Group type: COMPARATOR
Intervention: No adjuvant treatment
Number of subjects: 280
Study: 8409113

Group type: EXPERIMENTAL
Intervention: Aspartame (50, 300, 600 mg doses; half doses for subjects weighing less than 40 kg)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Aspartame
Number of subjects: 21
Study: 3531314

Group type: EXPERIMENTAL
Intervention: Cimetidine 1 g daily for 5 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo for 5 weeks
Number of subjects: 60
Study: 29737256

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 9340

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9340
Study: 28642811

Group type: EXPERIMENTAL
Intervention: Actinidia chinensis Planch. juice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (patients without taking the juice)
Number of subjects: 0
Study: 25884778

Group type: EXPERIMENTAL
Intervention: Diclegis® (doxylamine succinate 10 mg and pyridoxine hydrochloride 10 mg)
Number of subjects: 256

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 256
Study: 23727316

Group type: EXPERIMENTAL
Intervention: pICA-R
Number of subjects: 300
Study: 21680022

Group type: EXPERIMENTAL
Intervention: Latanoprost 0.005%
Number of subjects: 137

Group type: COMPARATOR
Intervention: Timolol 0.5% (0.25% for those aged <3 years)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Latanoprost 0.005% (PCG subgroup)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Timolol 0.5% (PCG subgroup)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Latanoprost 0.005% (non-PCG subgroup)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Timolol 0.5% (non-PCG subgroup)
Number of subjects: 137
Study: 18626766

Group type: EXPERIMENTAL
Intervention: Crisis Residential Program (CRP)
Number of subjects: 393

Group type: COMPARATOR
Intervention: Locked Inpatient Psychiatric Facility (LIPF)
Number of subjects: 393
Study: 16863773

Group type: EXPERIMENTAL
Intervention: On-pump surgery
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Off-pump surgery
Number of subjects: 212

Group type: COMPARATOR
Intervention: Both groups (on-pump and off-pump)
Number of subjects: 212
Study: 15175031

Group type: EXPERIMENTAL
Intervention: Anti-IL-5 monoclonal antibody (mepolizumab)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 24
Study: 11305700

Group type: EXPERIMENTAL
Intervention: Nefazodone, average end‐of‐treatment dose 376 mg/day
Number of subjects: 993
Study: 15251769

Group type: EXPERIMENTAL
Intervention: 70/30 insulin (premixed 30% regular insulin and 70% NPH insulin), administered twice daily for 4 weeks
Number of subjects: 90

Group type: COMPARATOR
Intervention: NPH insulin, administered twice daily for 4 weeks
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 70/30 insulin (premixed 30% regular insulin and 70% NPH insulin)
Number of subjects: 90

Group type: COMPARATOR
Intervention: NPH insulin
Number of subjects: 90
Study: 8327417

Group type: EXPERIMENTAL
Intervention: Intensive intervention strategies mediated through lay volunteers from participating churches
Number of subjects: 272

Group type: COMPARATOR
Intervention: Minimal (self-help) intervention strategies
Number of subjects: 272
Study: 3548733

Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 0

Group type: COMPARATOR
Intervention: HLA-DR2
Number of subjects: 0
Study: 31268211

Group type: EXPERIMENTAL
Intervention: Intervention group (multicomponent intervention including point‐of‐care FOBT provision, printed screening advice, and GP endorsement)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Usual care group (control)
Number of subjects: 123
Study: 28364253

Group type: EXPERIMENTAL
Intervention: Women with prediabetes (n=63)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Women with normal glucose tolerance (NGT) (n=39)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control participants (n=15)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Women with prediabetes
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Women with normal glucose tolerance (NGT)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control participants
Number of subjects: 102
Study: 25853533

Group type: EXPERIMENTAL
Intervention: Home visits conducted by family medicine residents
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine office-based newborn care
Number of subjects: 0
Study: 23740935

Group type: EXPERIMENTAL
Intervention: Neoadjuvant docetaxel and GVAX therapy
Number of subjects: 6
Study: 21217449

Group type: EXPERIMENTAL
Intervention: Anterior cervical discectomy and fusion (ACDF)
Number of subjects: 209

Group type: COMPARATOR
Intervention: Cervical total disc arthroplasty (TDA)
Number of subjects: 209
Study: 19665354

Group type: EXPERIMENTAL
Intervention: Group A (n=6) - roughened implant surface by sandblasting only
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Group B (n=12) - implant surface with additional macroretentions
Number of subjects: 18
Study: 17353819

Group type: EXPERIMENTAL
Intervention: SenSura bag
Number of subjects: 68

Group type: COMPARATOR
Intervention: Reference bag
Number of subjects: 68
Study: 14977029

Group type: EXPERIMENTAL
Intervention: Time pressure
Number of subjects: 0
Study: 11759182

Group type: EXPERIMENTAL
Intervention: PDRN (5625 mg/vial) administered intramuscularly once daily and subcutaneously (2 vials every 3 days) for 10 days
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo administered intramuscularly once daily and subcutaneously (2 vials every 3 days) for 10 days
Number of subjects: 26
Study: 9515241

Group type: EXPERIMENTAL
Intervention: Endoscopic sphincterotomy (ES) alone (n = 50)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Open cholecystectomy with operative cholangiography and (if necessary) bile duct exploration (n = 48)
Number of subjects: 98
Study: 8070199

Group type: EXPERIMENTAL
Intervention: Pulsing electromagnetic field stimulation
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (no pulsing electromagnetic field stimulation)
Number of subjects: 47
Study: 3277419

Group type: EXPERIMENTAL
Intervention: Indapamide 2.5 mg once daily
Number of subjects: 30

Group type: COMPARATOR
Intervention: Captopril 12.5 to 50 mg twice daily
Number of subjects: 30
Study: 31161289

Group type: EXPERIMENTAL
Intervention: TEP hernia repair
Number of subjects: 176

Group type: COMPARATOR
Intervention: Lichtenstein hernia repair
Number of subjects: 176
Study: 31018682

Group type: EXPERIMENTAL
Intervention: Linagliptin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dipeptidyl peptidase-4 inhibitors
Number of subjects: 0
Study: 29354948

Group type: EXPERIMENTAL
Intervention: Elongated needle
Number of subjects: 60

Group type: COMPARATOR
Intervention: Filiform needle
Number of subjects: 60

Group type: COMPARATOR
Intervention: Medication
Number of subjects: 60
Study: 25955246

Group type: EXPERIMENTAL
Intervention: Agalsidase beta (two doses)
Number of subjects: 31
Study: 23670318

Group type: EXPERIMENTAL
Intervention: Modified Epley maneuver
Number of subjects: 0
Study: 21256445

Group type: EXPERIMENTAL
Intervention: Endurance plus plyometric training
Number of subjects: 15

Group type: COMPARATOR
Intervention: Endurance only training (control group)
Number of subjects: 15
Study: 19229704

Group type: EXPERIMENTAL
Intervention: FORM + TIO
Number of subjects: 255

Group type: COMPARATOR
Intervention: TIO
Number of subjects: 255
Study: 16846545

Group type: EXPERIMENTAL
Intervention: RSV 10 mg/day
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: ATV 20 mg/day
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: RSV 10 mg/day and ATV 20 mg/day
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 120
Study: 12775859

Group type: EXPERIMENTAL
Intervention: Exhaled nitric oxide (FE(NO)) measurement
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Baseline lung function and bronchodilator responsiveness measured using impulse oscillometry (IOS)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Baseline lung function
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Receiver operating characteristics (ROC) analysis of FE(NO)
Number of subjects: 96
Study: 10862057

Group type: EXPERIMENTAL
Intervention: Magnetic resonance spectroscopy (MRS)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Magnetic resonance imaging (MRI)
Number of subjects: 5
Study: 9085949

Group type: EXPERIMENTAL
Intervention: Remifentanil 1.0 microg x kg(‐1) x min(‐1)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Remifentanil 1.5 microg x kg(‐1) x min(‐1)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Remifentanil 2.0 microg x kg(‐1) x min(‐1)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Remifentanil 1.0 microg x kg(‐1) x min(‐1) after surgery
Number of subjects: 10
Study: 8403274

Group type: EXPERIMENTAL
Intervention: Ivermectin (100 micrograms/kg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Diethylcarbamazine (DEC) (6 mg/kg)
Number of subjects: 60
Study: 6587752

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Verapamil and Propranolol
Number of subjects: 0
Study: 30825880

Group type: EXPERIMENTAL
Intervention: Training intervention for GPs consisting of lectures and workshops aimed at increasing work awareness and proactive counseling for patients with work-related problems.
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Training intervention for GPs
Number of subjects: 280

Group type: COMPARATOR
Intervention: Usual care by GPs in control group
Number of subjects: 280
Study: 30203494

Group type: EXPERIMENTAL
Intervention: Investigative device (Vesair Balloon) placement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 0
Study: 26748631

Group type: EXPERIMENTAL
Intervention: Prenatal lifestyle intervention
Number of subjects: 401

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 401
Study: 24415715

Group type: EXPERIMENTAL
Intervention: Pulmonary metastasectomy for colorectal cancer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pulmonary metastasectomy for sarcoma
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pulmonary metastasectomy for melanoma
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pulmonary metastasectomy for non-seminomatous germ cell tumors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repeated resections and ablations for lung and liver metastases
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomised controlled trial Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC)
Number of subjects: 0
Study: 20709233

Group type: EXPERIMENTAL
Intervention: Rimonabant 20 mg
Number of subjects: 18695

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18695
Study: 15599492

Group type: EXPERIMENTAL
Intervention: Comparative feedback on individual results (benchmarking)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Data-based quality circles including benchmarking
Number of subjects: 10
Study: 11588893

Group type: EXPERIMENTAL
Intervention: Multivitamin use
Number of subjects: 15387

Group type: EXPERIMENTAL
Intervention: Single supplements of vitamin C or E
Number of subjects: 15387

Group type: EXPERIMENTAL
Intervention: Antioxidant mixtures or single supplements of vitamins A and D, zinc, or beta-carotene
Number of subjects: 15387

Group type: EXPERIMENTAL
Intervention: Vitamin E intake from supplements
Number of subjects: 15387

Group type: EXPERIMENTAL
Intervention: Vitamins A, C, and D intake from supplements
Number of subjects: 15387

Group type: EXPERIMENTAL
Intervention: Beta-carotene, folate, and zinc intake from supplements
Number of subjects: 15387

Group type: EXPERIMENTAL
Intervention: Higher education and lower body mass index
Number of subjects: 15387

Group type: EXPERIMENTAL
Intervention: Racial demographics
Number of subjects: 15387
Study: 9614950

Group type: EXPERIMENTAL
Intervention: Radiotherapy of the pelvic lymphatics (45 Gy for suspected metastases, 50.4 Gy for proven metastases)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laparoscopic lymphadenectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hormonal therapy and radiotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Elective radiotherapy of pelvic lymphatics
Number of subjects: 0

Group type: COMPARATOR
Intervention: RTOG 75-06 study
Number of subjects: 0
Study: 7863731

Group type: EXPERIMENTAL
Intervention: Mebendazole (Janssen) given twice daily for three days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mebendazole (Janssen) single-dose treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mebendazole (Nordia)
Number of subjects: 0
Study: 2491829

Group type: EXPERIMENTAL
Intervention: Oral lithium carbonate 1200 mg daily
Number of subjects: 54

Group type: COMPARATOR
Intervention: No lithium (Control)
Number of subjects: 54
Study: 182014

Group type: EXPERIMENTAL
Intervention: Intracavitary irradiation
Number of subjects: 91

Group type: COMPARATOR
Intervention: External beam irradiation
Number of subjects: 91
Study: 29106693

Group type: EXPERIMENTAL
Intervention: Individualized metacognitive therapy (MCT+)
Number of subjects: 92

Group type: COMPARATOR
Intervention: CogPack (neuropsychological training)
Number of subjects: 92
Study: 26526324

Group type: EXPERIMENTAL
Intervention: High number of different sexual partners (vaginal and oral)
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Alcohol consumption
Number of subjects: 310
Study: 25139178

Group type: EXPERIMENTAL
Intervention: Alprazolam 0.75 mg
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 22515871

Group type: EXPERIMENTAL
Intervention: HIV risk-reduction counseling with on-site rapid HIV testing
Number of subjects: 1281

Group type: EXPERIMENTAL
Intervention: Verbal information about testing only with on-site rapid HIV testing
Number of subjects: 1281

Group type: COMPARATOR
Intervention: Referral for off-site HIV testing
Number of subjects: 1281
Study: 20723869

Group type: EXPERIMENTAL
Intervention: Upward probability revision
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Downward probability revision
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher probability estimate than previous speaker
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lower probability estimate than previous speaker
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Selection of probability phrases for two different suspects
Number of subjects: 0
Study: 18784543

Group type: EXPERIMENTAL
Intervention: Oxygen
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 16029401

Group type: EXPERIMENTAL
Intervention: i.v. paracetamol 15 mg.kg(‐1)
Number of subjects: 183

Group type: COMPARATOR
Intervention: propacetamol 30 mg.kg(‐1)
Number of subjects: 183
Study: 12505969

Group type: EXPERIMENTAL
Intervention: 1 mg/kg of 2% lidocaine sprayed down the ETT 5 min before extubation (Group 2)
Number of subjects: 75

Group type: COMPARATOR
Intervention: No drug (Group 1)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: IV lidocaine (IVL) 3 min before extubation (Group 3)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Lidocaine sprayed down the ETT (Group 2)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control (Group 1)
Number of subjects: 75
Study: 12212217

Group type: EXPERIMENTAL
Intervention: Propofol 2 mg.kg‐1
Number of subjects: 30

Group type: COMPARATOR
Intervention: Propofol 1 mg.kg‐1 combined with Ketamine
Number of subjects: 30